We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy
Evidence-based coverage of pharmaceutical development, regulatory affairs, and biotech innovation
A new experimental Alzheimer’s drug called donanemab is generating major excitement as a potential breakthrough in treating the disease. In a large-scale clinical trial sponsored by pharmaceutical com
Read ArticleResearchers claim to have made progress in developing a vaccine that will protect against all 20 forms of influenza. The effective Covid vaccines employ the same messenger-ribonucleic acid (mRNA) tech
It has been called "historic" that the first drug to slow the brain damage caused by Alzheimer's has been made. The scientific discovery puts a stop to decades of futility and demonstrates that new me
It is still attempting to resolve the fundamental issue. In general, Mark Cuban's new online pharmacy is delivering on its promises of offering low savings on hundreds of prescription medications. The
Subscribe to our weekly pharmaceutical intelligence digest